chemotherapy: be for just cancer

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be for just cancer 1.00
be just used for cancer 0.98
be for cancer 0.97
has state cancer 0.92
be more important than other cancer 0.91
treat cancer 0.89
be used for breast cancer 0.88
be most common cancer for men 0.88
be effective in cancer treatment 0.87
be for lymphoma 0.86

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.53
Rule weight: 0.66
Evidence weight: 0.92
Similarity weight: 0.86
Evidence: 0.91
Plausible(treatment, be for lymphoma)
Evidence: 0.90
¬ Typical(chemotherapy, be for just cancer)
0.52
Rule weight: 0.66
Evidence weight: 0.89
Similarity weight: 0.88
Evidence: 0.88
Plausible(prostate cancer, be most common cancer for men)
Evidence: 0.90
¬ Typical(chemotherapy, be for just cancer)
0.50
Rule weight: 0.66
Evidence weight: 0.86
Similarity weight: 0.87
Evidence: 0.85
Plausible(agent, be effective in cancer treatment)
Evidence: 0.90
¬ Typical(chemotherapy, be for just cancer)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.88
Similarity weight: 0.88
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.88
¬ Plausible(prostate cancer, be most common cancer for men)
0.07
Rule weight: 0.09
Evidence weight: 0.89
Similarity weight: 0.87
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.85
¬ Plausible(agent, be effective in cancer treatment)
0.07
Rule weight: 0.09
Evidence weight: 0.88
Similarity weight: 0.86
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.91
¬ Plausible(treatment, be for lymphoma)

Remarkability exclusitivity betweem a parent and a child

0.36
Rule weight: 0.58
Evidence weight: 0.71
Similarity weight: 0.87
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment)
0.33
Rule weight: 0.58
Evidence weight: 0.66
Similarity weight: 0.86
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma)
0.27
Rule weight: 0.58
Evidence weight: 0.54
Similarity weight: 0.88
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.69
¬ Remarkable(prostate cancer, be most common cancer for men)

Remarkability exclusitivity between siblings

0.07
Rule weight: 0.13
Evidence weight: 0.61
Similarity weight: 0.89
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.58
¬ Remarkable(gene therapy, treat cancer)
0.07
Rule weight: 0.13
Evidence weight: 0.56
Similarity weight: 0.91
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.65
¬ Remarkable(breast cancer, be more important than other cancer)
0.05
Rule weight: 0.13
Evidence weight: 0.42
Similarity weight: 0.92
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.86
¬ Remarkable(breast cancer, has state cancer)

Remarkability from parent implausibility

0.35
Rule weight: 0.42
Evidence weight: 0.97
Similarity weight: 0.88
Evidence: 0.88
Plausible(prostate cancer, be most common cancer for men)
Evidence: 0.67
Remarkable(chemotherapy, be for just cancer)
Evidence: 0.87
¬ Plausible(chemotherapy, be for just cancer)
0.35
Rule weight: 0.42
Evidence weight: 0.97
Similarity weight: 0.86
Evidence: 0.91
Plausible(treatment, be for lymphoma)
Evidence: 0.67
Remarkable(chemotherapy, be for just cancer)
Evidence: 0.87
¬ Plausible(chemotherapy, be for just cancer)
0.35
Rule weight: 0.42
Evidence weight: 0.96
Similarity weight: 0.87
Evidence: 0.85
Plausible(agent, be effective in cancer treatment)
Evidence: 0.67
Remarkable(chemotherapy, be for just cancer)
Evidence: 0.87
¬ Plausible(chemotherapy, be for just cancer)

Remarkability from sibling implausibility

0.55
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.92
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.86
Remarkable(breast cancer, has state cancer)
Evidence: 0.32
¬ Plausible(breast cancer, has state cancer)
0.52
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.91
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.65
Remarkable(breast cancer, be more important than other cancer)
Evidence: 0.86
¬ Plausible(breast cancer, be more important than other cancer)
0.51
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.89
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.58
Remarkable(gene therapy, treat cancer)
Evidence: 0.84
¬ Plausible(gene therapy, treat cancer)

Salient implies Plausible

0.25
Rule weight: 0.28
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.94
¬ Salient(chemotherapy, be for just cancer)

Similarity expansion

0.79
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.98
Evidence: 0.94
Salient(chemotherapy, be for just cancer)
Evidence: 0.89
¬ Salient(chemotherapy, be just used for cancer)
0.78
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.97
Evidence: 0.94
Salient(chemotherapy, be for just cancer)
Evidence: 0.81
¬ Salient(chemotherapy, be for cancer)
0.78
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.97
Evidence: 0.90
Typical(chemotherapy, be for just cancer)
Evidence: 0.52
¬ Typical(chemotherapy, be for cancer)
0.78
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.98
Evidence: 0.90
Typical(chemotherapy, be for just cancer)
Evidence: 0.68
¬ Typical(chemotherapy, be just used for cancer)
0.76
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.97
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.61
¬ Plausible(chemotherapy, be for cancer)
0.75
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.98
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.73
¬ Plausible(chemotherapy, be just used for cancer)
0.71
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.88
Evidence: 0.94
Salient(chemotherapy, be for just cancer)
Evidence: 0.92
¬ Salient(chemotherapy, be used for breast cancer)
0.69
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.88
Evidence: 0.90
Typical(chemotherapy, be for just cancer)
Evidence: 0.79
¬ Typical(chemotherapy, be used for breast cancer)
0.67
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.88
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.81
¬ Plausible(chemotherapy, be used for breast cancer)
0.61
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.98
Evidence: 0.67
Remarkable(chemotherapy, be for just cancer)
Evidence: 0.81
¬ Remarkable(chemotherapy, be just used for cancer)
0.59
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.97
Evidence: 0.67
Remarkable(chemotherapy, be for just cancer)
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
0.56
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.88
Evidence: 0.67
Remarkable(chemotherapy, be for just cancer)
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.94
Salient(chemotherapy, be for just cancer)
Evidence: 0.90
¬ Typical(chemotherapy, be for just cancer)
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)

Typical implies Plausible

0.42
Rule weight: 0.48
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.87
Plausible(chemotherapy, be for just cancer)
Evidence: 0.90
¬ Typical(chemotherapy, be for just cancer)

Typicality and Rermarkability incompatibility between a parent and a child

0.17
Rule weight: 0.51
Evidence weight: 0.39
Similarity weight: 0.88
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.91
¬ Typical(prostate cancer, be most common cancer for men)
0.16
Rule weight: 0.51
Evidence weight: 0.37
Similarity weight: 0.87
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)
0.16
Rule weight: 0.51
Evidence weight: 0.36
Similarity weight: 0.86
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.96
¬ Typical(treatment, be for lymphoma)

Typicality and Rermarkability incompatibility between siblings

0.11
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 0.92
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.17
¬ Typical(breast cancer, has state cancer)
0.05
Rule weight: 0.14
Evidence weight: 0.40
Similarity weight: 0.89
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.89
¬ Typical(gene therapy, treat cancer)
0.05
Rule weight: 0.14
Evidence weight: 0.39
Similarity weight: 0.91
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
Evidence: 0.91
¬ Typical(breast cancer, be more important than other cancer)

Typicality inheritance from parent to child

0.39
Rule weight: 0.48
Evidence weight: 0.91
Similarity weight: 0.88
Evidence: 0.90
Typical(chemotherapy, be for just cancer)
Evidence: 0.91
¬ Typical(prostate cancer, be most common cancer for men)
0.38
Rule weight: 0.48
Evidence weight: 0.90
Similarity weight: 0.87
Evidence: 0.90
Typical(chemotherapy, be for just cancer)
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)
0.38
Rule weight: 0.48
Evidence weight: 0.90
Similarity weight: 0.86
Evidence: 0.90
Typical(chemotherapy, be for just cancer)
Evidence: 0.96
¬ Typical(treatment, be for lymphoma)